## **Core Concept**
The administration of Gonadotropin-Releasing Hormone (GnRH) plays a crucial role in regulating the reproductive endocrine system. GnRH is a key hormone that stimulates the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. The effect of GnRH on the pituitary gland depends on its mode of administration - pulsatile or continuous.

## **Why the Correct Answer is Right**
Continuous administration of GnRH leads to **downregulation** and **desensitization** of GnRH receptors in the pituitary gland. This is because continuous exposure to GnRH causes an initial surge in LH and FSH secretion, followed by a decrease in the number of GnRH receptors and a subsequent decrease in LH and FSH secretion. This mechanism is utilized clinically in the treatment of hormone-sensitive cancers like prostate cancer and in precocious puberty.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because pulsatile administration of GnRH, not continuous, leads to an increase in LH and FSH secretion. This is the physiological pattern of GnRH release that stimulates the normal menstrual cycle and spermatogenesis.
- **Option B:** This option is incorrect because continuous administration of GnRH does not simply maintain basal levels of LH and FSH; rather, it suppresses their secretion.
- **Option C:** This option might seem plausible but is incorrect in the context of continuous GnRH administration effects. Continuous GnRH can initially stimulate but ultimately leads to suppression.

## **Clinical Pearl / High-Yield Fact**
A key clinical application of continuous GnRH administration is in the treatment of **prostate cancer**. By suppressing LH and FSH secretion, continuous GnRH agonist therapy reduces testosterone production, which can slow the growth of prostate cancer cells that are often testosterone-dependent.

## **Correct Answer:** . Decreases LH and FSH secretion.